Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EBBH-2026 by Essen Biotech for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
EBBH-2026 is under clinical development by Essen Biotech and currently in Phase II for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute...